Studies on the relationship between the effects of various substances on absorption spectrum of cytochrome P-450 and the reduction of p-nitrobenzoate by mouse liver microsomes.
D000632:Aminopyrine / Q000494:pharmacology; D000814:Aniline Compounds / Q000494:pharmacology; D000818:Animals; D001565:Benzoates / Q000378:metabolism*; D002248:Carbon Monoxide; D003580:Cytochromes / Q000378:metabolism*; D005021:Ethylamines / Q000494:pharmacology; D006591:Hexobarbital / Q000494:pharmacology; D007093:Imidazoles / Q000494:pharmacology; D066298:In Vitro Techniques; D007700:Kinetics; D008099:Liver / Q000201:enzymology*; D008297:Male; D051379:Mice; D008861:Microsomes / Q000201:enzymology*; D009019:Morphinans / Q000494:pharmacology; D009249:NADP / Q000378:metabolism; D009536:Niacinamide / Q000494:pharmacology; D010084:Oxidation-Reduction; D010088:Oxidoreductases / Q000037:antagonists & inhibitors*; D011335:Proadifen / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology; D013053:Spectrophotometry
D000814:Aniline Compounds; D001565:Benzoates; D003580:Cytochromes; D005021:Ethylamines; D007093:Imidazoles; D009019:Morphinans; D011725:Pyridines; D000632:Aminopyrine; D009536:Niacinamide; D009249:NADP; D002248:Carbon Monoxide; D011335:Proadifen; D006591:Hexobarbital; D010088:Oxidoreductases